One of these patients, a 15-year-old boy with biopsy proven differentiated teratoma has received 2 courses of lymphoblastoid IFN and 1 course of recombinant leukocyte A IFN (Roche Products Ltd.)lasting 5 1/2, 8 and 8+ months respectively. This evidence concerns the gene IFNA1 and teratoma.